Neurology updates

Neurologists stay aware of COVID-19 brain stem involvement The major clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection are due to pulmonary complications. The majority of the patients so far in the COVID-19 pandemic had milder symptoms… Continue Reading

Cutaneous silent periods Cutaneous silent period is a useful, although underestimated tool for the clinical assessment of poly neuropathy as well as other neurological condition. This review provides an up to date on the physiology and methodology for its use… Continue Reading

Breaking news in Neuro-Oncology

Tranexamic Acid administered after Traumatic Brain Injury may reduce mortality

Vagal nerve stimulation may improve post-stroke motor recovery

Expanding the expansions in hereditary ataxias

Multiple system atrophy (MSA) is a rare, fatal, neurodegenerative disease of the adulthood presenting with progressive autonomic failure, parkinsonian, cerebellar and pyramidal features in various combinations.

Findings suggest narcolepsy type 1 to be a T-cell mediated autoimmune disease targeting hypocretin-producing neurons.

Nakalanga syndrome: Clinical characteristics, potential causes, and its relationship with recently described Nodding syndrome

New treatment options for pediatric convulsive status epilepticus after failure of first-line benzodiazepines

Zika virus circulation has decreased but there is a possibility of its emergence or re-emergence in all areas with competent mosquito vectors.

Levetiracetam and NOACs

Second dose of intravenous immunoglobulin for Guillain-Barre syndrome

Antiparanodal antibodies in CIDP.

Role of right frontal regions in cognition: evidence from intraoperative stimulation in awake people